{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T04:01:47Z","timestamp":1773720107717,"version":"3.50.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2008,11,5]],"date-time":"2008-11-05T00:00:00Z","timestamp":1225843200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Med"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1186\/1741-7015-6-33","type":"journal-article","created":{"date-parts":[[2008,11,5]],"date-time":"2008-11-05T20:28:32Z","timestamp":1225916912000},"source":"Crossref","is-referenced-by-count":20,"title":["LRRK2in Parkinson's disease \u2013 drawing the curtain of penetrance: a commentary"],"prefix":"10.1186","volume":"6","author":[{"given":"Rejko","family":"Kr\u00fcger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,11,5]]},"reference":[{"key":"173_CR1","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1111\/j.1365-2990.2008.00952.x","volume":"34","author":"C Schiesling","year":"2008","unstructured":"Schiesling C, Kieper N, Seidel K, Kr\u00fcger R: Familial PD \u2013 genetics, clinical phenotype and neuropathology in relation to the common sporadic form of the disease. Neuropathol Appl Neurobiol. 2008, 34: 255-271. 10.1111\/j.1365-2990.2008.00952.x.","journal-title":"Neuropathol Appl Neurobiol"},{"key":"173_CR2","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.neuron.2004.11.005","volume":"44","author":"A Zimprich","year":"2004","unstructured":"Zimprich A, Biskup S, Leitner P, Lichtner P, Farrer M, Lincoln S, Kachergus J, Hulihan M, Uitti RJ, Calne DB, Stoessl AJ, Pfeiffer RF, Patenge N, Carbajal IC, Vieregge P, Asmus F, Muller-Myhsok B, Dickson DW, Meitinger T, Strom TM, Wszolek ZK, Gasser T: Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron. 2004, 44: 601-607. 10.1016\/j.neuron.2004.11.005.","journal-title":"Neuron"},{"key":"173_CR3","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.neuron.2004.10.023","volume":"44","author":"C Paisan-Ruiz","year":"2004","unstructured":"Paisan-Ruiz C, Jain S, Evans EW, Gilks WP, Simon J, Brug van der M, Lopez de Munain A, Aparicio S, Gil AM, Khan N, Johnson J, Martinez JR, Nicholl D, Carrera IM, Pena AS, de Silva R, Lees A, Marti-Masso JF, Perez-Tur J, Wood NW, Singleton AB: Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease. Neuron. 2004, 44: 595-600. 10.1016\/j.neuron.2004.10.023.","journal-title":"Neuron"},{"key":"173_CR4","doi-asserted-by":"crossref","first-page":"3000","DOI":"10.1093\/brain\/awh666","volume":"128","author":"D Berg","year":"2005","unstructured":"Berg D, Schweitzer K, Leitner P, Zimprich A, Lichtner P, Belcredi P, Brussel T, Schulte C, Maass S, Nagele T: Type and frequency of mutations in the LRRK2 gene in familial and sporadic Parkinson's disease. Brain. 2005, 128: 3000-3011.","journal-title":"Brain"},{"key":"173_CR5","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1056\/NEJMc055540","volume":"354","author":"S Lesage","year":"2006","unstructured":"Lesage S, Durr A, Tazir M, Lohmann E, Leutenegger AL, Janin S, Pollak P, Brice A: LRRK2 G2019S as a cause of Parkinson's disease in North African Arabs. N Engl J Med. 2006, 354: 422-423. 10.1056\/NEJMc055540.","journal-title":"N Engl J Med"},{"key":"173_CR6","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/S1474-4422(08)70117-0","volume":"7","author":"DG Healy","year":"2008","unstructured":"Healy DG, Falchi M, O'Sullivan SS, Bonifati V, Durr A, Bressman S, Brice A, Aasly J, Zabetian CP, Goldwurm S, Ferreira JJ, Tolosa E, Kay DM, Klein C, Williams DR, Marras C, Lang AE, Wszolek ZK, Berciano J, Schapira AH, Lynch T, Bhatia KP, Gasser T, Lees AJ, Wood NW, International LRRK2 Consortium: Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study. Lancet Neurol. 2008, 7: 583-590. 10.1016\/S1474-4422(08)70117-0.","journal-title":"Lancet Neurol"},{"key":"173_CR7","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/S1474-4422(08)70116-9","volume":"7","author":"MM Hulihan","year":"2008","unstructured":"Hulihan MM, Ishihara-Paul L, Kachergus J, Warren L, Amouri R, Elango R, Prinjha RK, Upmanyu R, Kefi M, Zouari M, Sassi SB, Yahmed SB, El Euch Fayeche G, Matthews PM, Middleton LT, Gibson RA, Hentati F, Farrer MJ: LRRK2 Gly2019Ser penetrance in Arab-Berber patients from Tunisia: a case-control genetic study. Lancet Neurol. 2008, 7: 591-594. 10.1016\/S1474-4422(08)70116-9.","journal-title":"Lancet Neurol"},{"key":"173_CR8","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/S0140-6736(05)17829-5","volume":"365","author":"A Di Fonzo","year":"2005","unstructured":"Di Fonzo A, Rohe CF, Ferreira J, Chien HF, Vacca L, Stocchi F, Guedes L, Fabrizio E, Manfredi M, Vanacore N, Goldwurm S, Breedveld G, Sampaio C, Meco G, Barbosa E, Oostra BA, Bonifati V: A frequent LRRK2 gene mutation associated with autosomal dominant Parkinson's disease. Lancet. 2005, 365: 412-415.","journal-title":"Lancet"},{"key":"173_CR9","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.tins.2006.03.006","volume":"29","author":"IF Mata","year":"2006","unstructured":"Mata IF, Wedemeyer WJ, Farrer MJ, Taylor JP, Gallo KA: LRRK2 in Parkinson's disease: protein domains and functional insights. Trends Neurosci. 2006, 29: 286-293. 10.1016\/j.tins.2006.03.006.","journal-title":"Trends Neurosci"},{"key":"173_CR10","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1212\/01.wnl.0000254483.19854.ef","volume":"68","author":"S Goldwurm","year":"2007","unstructured":"Goldwurm S, Zini M, Mariani L, Tesei S, Miceli R, Sironi F, Clementi M, Bonifati V, Pezzoli G: Evaluation of LRRK2 G2019S penetrance. Neurology. 2007, 68: 1141-1143. 10.1212\/01.wnl.0000254483.19854.ef.","journal-title":"Neurology"},{"key":"173_CR11","volume-title":"BMC Medicine","author":"JC Latourelle","year":"2008","unstructured":"Latourelle JC, Sun M, Lew MF, Suchowersky O, Klein C, Golbe LI, Mark MH, Growdon JH, Wooten F, et al: The G2019S mutation in LRRK2 is not fully penetrant: The GenePD study. BMC Medicine. 2008"},{"key":"173_CR12","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1056\/NEJMc055509","volume":"354","author":"LJ Ozelius","year":"2006","unstructured":"Ozelius LJ, Senthil G, Saunders-Pullman R, Ohmann E, Deligtisch A, Tagliati M, Hunt AL, Klein C, Henick B, Hailpern SM, Lipton RB, Soto-Valencia J, Risch N, Bressman SB: LRRK2 G2019S as a cause of Parkinson's disease in Ashkenazi Jews. N Engl J Med. 2006, 354: 424-425. 10.1056\/NEJMc055509.","journal-title":"N Engl J Med"},{"key":"173_CR13","first-page":"221","volume":"94","author":"CB Begg","year":"2002","unstructured":"Begg CB: On the use of familial aggregation in population-based case probands for calculating penetrance. J Natl Cancer Inst. 2002, 94: 221-226.","journal-title":"J Natl Cancer Inst"},{"key":"173_CR14","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","volume":"276","author":"MH Polymeropoulos","year":"1997","unstructured":"Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A, Pike B, Root H, Rubenstein J, Boyer R, Stenroos ES, Chandrasekharappa S, Athanassiadou A, Papapetropoulos T, Johnson WG, Lazzarini AM, Duvoisin RC, Di Iorio G, Golbe LI, Nussbaum RL: Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science. 1997, 276: 2045-2047. 10.1126\/science.276.5321.2045.","journal-title":"Science"},{"key":"173_CR15","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1002\/ana.20587","volume":"58","author":"PP Pramstaller","year":"2005","unstructured":"Pramstaller PP, Schlossmacher MG, Jacques TS, Scaravilli F, Eskelson C, Pepivani I, Hedrich K, Adel S, Gonzales-McNeal M, Hilker R, Kramer PL, Klein C: Lewy body Parkinson's disease in a large pedigree with 77 Parkin mutation carriers. Ann Neurol. 2005, 58: 411-422. 10.1002\/ana.20587.","journal-title":"Ann Neurol"},{"key":"173_CR16","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1136\/bmj.321.7252.21","volume":"321","author":"A Schrag","year":"2000","unstructured":"Schrag A, Ben-Shlomo Y, Quinn NP: Cross-sectional prevalence survey of idiopathic Parkinson's disease and Parkinsonism in London. BMJ. 2000, 321: 21-22. 10.1136\/bmj.321.7252.21.","journal-title":"BMJ"},{"key":"173_CR17","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1001\/archneur.63.6.833","volume":"63","author":"K Hedrich","year":"2006","unstructured":"Hedrich K, Hagenah J, Djarmati A, Hiller A, Lohnau T, Lasek K, Grunewald A, Hilker R, Steinlechner S, Boston H, Kock N, Schneider-Gold C, Kress W, Siebner H, Binkofski F, Lencer R, Munchau A, Klein C: Clinical spectrum of homozygous and heterozygous PINK1 mutations in a large German family with Parkinson disease: role of a single hit?. Arch Neurol. 2006, 63: 833-838. 10.1001\/archneur.63.6.833.","journal-title":"Arch Neurol"},{"key":"173_CR18","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/S1474-4422(07)70174-6","volume":"6","author":"C Klein","year":"2007","unstructured":"Klein C, Lohmann-Hedrich K, Rogaeva E, Schlossmacher MG, Lang AE: Deciphering the role of heterozygous mutations in genes associated with parkinsonism. Lancet Neurol. 2007, 6: 652-662. 10.1016\/S1474-4422(07)70174-6.","journal-title":"Lancet Neurol"},{"key":"173_CR19","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1212\/01.wnl.0000304044.22253.03","volume":"70","author":"K Haugarvoll","year":"2008","unstructured":"Haugarvoll K, Rademakers R, Kachergus JM, Nuytemans K, Ross OA, Gibson JM, Tan EK, Gaig C, Tolosa E, Goldwurm S, Guidi M, Riboldazzi G, Brown L, Walter U, Benecke R, Berg D, Gasser T, Theuns J, Pals P, Cras P, Paul De Deyn P, Engelborghs S, Pickut B, Uitti RJ, Foroud T, Nichols WC, Hagenah J, Klein C, Samii A, Zabetian CP, Bonifati V, Van Broeckhoven C, Farrer MJ, Wszolek ZK: Lrrk2 R1441C parkinsonism is clinically similar to sporadic Parkinson disease. Neurology. 2008, 70: 1456-1460. 10.1212\/01.wnl.0000304044.22253.03.","journal-title":"Neurology"},{"key":"173_CR20","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1001\/jama.296.6.661","volume":"296","author":"DM Maraganore","year":"2006","unstructured":"Maraganore DM, de Andrade M, Elbaz A, Farrer MJ, Ioannidis JP, Kruger R, Rocca WA, Schneider NK, Lesnick TG, Lincoln SJ, Hulihan MM, Aasly JO, Ashizawa T, Chartier-Harlin MC, Checkoway H, Ferrarese C, Hadjigeorgiou G, Hattori N, Kawakami H, Lambert JC, Lynch T, Mellick GD, Papapetropoulos S, Parsian A, Quattrone A, Riess O, Tan EK, Van Broeckhoven C: Collaborative analysis of alpha-synuclein gene promoter variability and Parkinson disease. JAMA. 2006, 296: 661-670. 10.1001\/jama.296.6.661.","journal-title":"JAMA"},{"key":"173_CR21","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1096\/fj.07-9348com","volume":"22","author":"J Fuchs","year":"2008","unstructured":"Fuchs J, Tichopad A, Golub Y, Munz M, Schweitzer KJ, Wolf B, Berg D, Mueller JC, Gasser T: Genetic variability in the SNCA gene influences alpha-synuclein levels in the blood and brain. FASEB J. 2008, 22: 1327-1334. 10.1096\/fj.07-9348com.","journal-title":"FASEB J"},{"key":"173_CR22","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.neulet.2006.06.068","volume":"410","author":"JC D\u00e4chsel","year":"2006","unstructured":"D\u00e4chsel JC, Mata IF, Ross OA, Taylor JP, Lincoln SJ, Hinkle KM, Huerta Ribacoba R, Blazquez M, Alvarez V, Farrer MJ: Digenic parkinsonism: investigation of the synergistic effects of PRKN and LRRK2. Neurosci Lett. 2006, 410: 80-84. 10.1016\/j.neulet.2006.06.068.","journal-title":"Neurosci Lett"},{"key":"173_CR23","volume-title":"Neurobiol Aging","author":"C Marras","year":"2008","unstructured":"Marras C, Klein C, Lang AE, Wakutani Y, Moreno D, Sato C, Yip E, Munhoz RP, Lohmann K, Djarmati A, Bi A, Rogaeva E: LRRK2 and Parkin mutations in a family with parkinsonism-Lack of genotype-phenotype correlation. Neurobiol Aging. 2008."},{"key":"173_CR24","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1002\/mds.21067","volume":"21","author":"J Hardy","year":"2006","unstructured":"Hardy J: No definitive evidence for a role for the environment in the etiology of Parkinson's disease. Mov Disord. 2006, 21: 1790-1791. 10.1002\/mds.21067.","journal-title":"Mov Disord"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1741-7015-6-33.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1741-7015-6-33\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1741-7015-6-33.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,15]],"date-time":"2019-05-15T03:29:55Z","timestamp":1557890995000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/1741-7015-6-33"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11,5]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["173"],"URL":"https:\/\/doi.org\/10.1186\/1741-7015-6-33","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,11,5]]},"article-number":"33"}}